News

New Guidance for Diabetes Equipment Users The MHRA has published updated guidance to help users of insulin pumps and continuous glucose monitoring (CGM) equipment report suspected adverse incidents and safety concerns through the Yellow Card scheme. What You Need to Know This guidance is aimed at: Users of insulin pumps and CGM devices Family members […]

Blood Pressure Monitoring Required for Bromocriptine Use The MHRA has issued a safety update following a Yellow Card report concerning bromocriptine prescribed for prevention or inhibition of post-partum physiological lactation. A safety review has concluded that blood pressure monitoring is essential when prescribing this medication. Key Points Bromocriptine carries a risk of blood pressure elevation […]

MHRA Drug Safety Update: September 2024 The MHRA has published a summary of letters and notifications issued to healthcare professionals during September 2024 concerning medicines and medical devices. This regular update ensures all clinical staff remain informed of important safety communications and product recalls. What You Need to Know The September 2024 alert package includes […]

August 2024 MHRA Safety Communications The MHRA has published a summary of letters and notifications issued to healthcare professionals during August 2024 concerning medicines and medical devices. This update consolidates recent safety communications to help you stay informed of regulatory actions affecting your practice. What You Need to Know The August 2024 communications package includes […]

Key Safety Update The MHRA has issued a precautionary safety alert regarding valproate use in men. A retrospective observational study has identified a possible association between valproate use by men around the time of conception and an increased risk of neurodevelopmental disorders in their children. What You Need to Know The alert applies to male […]

Yellow Card Biobank: Contributing to pharmacogenetic research The MHRA is inviting healthcare professionals and patients to contribute to an important research initiative exploring the genetic basis of side effects associated with two commonly prescribed medication classes. What is the Yellow Card Biobank? The Yellow Card Biobank is a collaborative study designed to investigate whether genetic […]

Important Safety Updates from the MHRA The Medicines and Healthcare products Regulatory Agency (MHRA) has published a summary of letters and notifications issued to healthcare professionals during July 2024. These communications cover a range of medicines and medical devices and include safety alerts, recalls, and important clinical guidance. What You Need to Know This monthly […]

Safety Alert: Epimax Ointment Products The MHRA has issued a safety alert regarding Epimax Ointment and Epimax Paraffin-Free Ointment due to reports of ocular surface toxicity and ocular chemical injury. Key Points Both Epimax Ointment and Epimax Paraffin-Free Ointment can cause serious eye damage if applied to the face Cases of ocular surface toxicity and […]

Important Safety Update from the MHRA The Medicines and Healthcare products Regulatory Agency (MHRA) has published a summary of letters and notifications issued to healthcare professionals during June 2024. This update covers recent medicine recalls and safety communications affecting clinical practice. What You Need to Know The MHRA regularly issues safety alerts and recalls to […]

Important Safety Update: Topiramate (Topamax) The MHRA has introduced new safety measures for topiramate following a comprehensive review of its use in pregnancy. Topiramate is now contraindicated in pregnancy and in women of childbearing potential unless strict conditions are met. Key Points Topiramate carries a significant risk of birth defects and developmental disorders when used […]